Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0522-2027

ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component. Recall

ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component.

FDA recall Class II

Open , Classified

FDA lists this Class II recall for ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0522-2027
Recall classification
Class II
FDA database status
Open , Classified
Initiation date
Oct 28, 2026
FDA website posting date
Nov 20, 2026
Quantity in commerce
9
Distribution
See key details
FDA cause
Not reported

What is being recalled?

ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component.

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

UDI-DI (GTIN) 10603295041283 Lot MN0418

View the original FDA recall notice

Why was this product recalled?

Size 4 implants incorrectly labeled as Size 5N on the outer boxes. If the issue is detected prior to implantation, it may result in a minor surgical delay. Implantation of an oversized device may lead to bone damage, loosening, or poor joint mechanics.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did DePuy Orthopaedics, Inc. take?

The firm began notifying customers on 10/28/26 via letters titled URGENT MEDICAL DEVICE REMOVAL. Customers were instructed to examine their inventory to determine if they have affected product. Affected product should be quarantined immediately. Do NOT use the subject product lot. Customers should contact their DePuy Synthes Sales Consultant or contact customer support services to coordinate the return/credits of the subject products. Customers should forward the notice to anyone in their facility who needs to be informed, and post a copy of the notice in a visible area for awareness.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology